Appili Therapeutics (OTCMKTS:APLIF – Get Free Report) posted its earnings results on Tuesday. The company reported ($0.01) EPS for the quarter, hitting the consensus estimate of ($0.01), Yahoo Finance reports.
Appili Therapeutics Stock Performance
Shares of OTCMKTS:APLIF remained flat at $0.02 during midday trading on Wednesday. The stock’s 50-day simple moving average is $0.03 and its two-hundred day simple moving average is $0.03. Appili Therapeutics has a fifty-two week low of $0.02 and a fifty-two week high of $0.07. The stock has a market cap of $2.92 million, a price-to-earnings ratio of -0.80 and a beta of -0.49.
Appili Therapeutics Company Profile
Featured Stories
- Five stocks we like better than Appili Therapeutics
- Are Penny Stocks a Good Fit for Your Portfolio?
- Serve Robotics Is Serving Up a Selling Opportunity
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Defying the Market: 3 Mega-Cap Stocks Soaring to New Highs
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Microsoft Stock: Is Now The Time To Be Greedy?
Receive News & Ratings for Appili Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Appili Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.